Journal Home
Search for

Volume 20, Issue 3, Pages 236-241 (May 2009)


View previous. 5 of 31 View next.

Systemic lupus erythematosus and vaccination

Arnaud MilletCorresponding Author Informationemail address, Olivier Decaux, Antoinette Perlat, Bernard Grosbois, Patrick Jego

Received 13 April 2008; received in revised form 25 June 2008; accepted 7 July 2008. published online 01 September 2008.

Abstract 

Patients with systemic lupus erythematosus (SLE) are frequently immunodepressed making them more vulnerable to infections. Preventive vaccination is therefore warranted but has often been withheld owing to fears of a link between infection and autoimmunity, and the possibility of inducing or exacerbating lupus after vaccination. The data published in the literature suggest that vaccination of lupus patient is safe, except for live vaccines. Their efficacy is lower than in healthy subjects but protection seems to be sufficient. But further large-scale studies are required to confirm these statements.

Department of Internal Medicine, CHU RENNES, France

Corresponding Author InformationCorresponding author. Department of Internal Medicine, Hôpital Sud, 16 Boulevard de Bulgarie, 35203 RENNES, France. Tel.: +33 2 99 26 71 28; fax: +33 2 99 26 71 98.

PII: S0953-6205(08)00215-X

doi:10.1016/j.ejim.2008.07.017


View previous. 5 of 31 View next.